Display options
Share it on

Clin Kidney J. 2015 Oct;8(5):538-42. doi: 10.1093/ckj/sfv063. Epub 2015 Jul 20.

Variability in phenotype induced by the podocin variant R229Q plus a single pathogenic mutation.

Clinical kidney journal

Paul J Phelan, Gentzon Hall, Delbert Wigfall, John Foreman, Shashi Nagaraj, Andrew F Malone, Michelle P Winn, David N Howell, Rasheed Gbadegesin

Affiliations

  1. Duke Molecular Physiology Institute , Duke University , Durham, NC , USA ; Division of Nephrology, Department of Medicine , Duke University Medical Center , Durham, NC , USA ; Department of Nephrology , Royal Infirmary of Edinburgh, NHS Lothian , Edinburgh , UK.
  2. Duke Molecular Physiology Institute , Duke University , Durham, NC , USA ; Division of Nephrology, Department of Medicine , Duke University Medical Center , Durham, NC , USA.
  3. Department of Nephrology , Royal Infirmary of Edinburgh, NHS Lothian , Edinburgh , UK.
  4. Department of Pathology , Duke University Medical Center , Durham, NC , USA.
  5. Duke Molecular Physiology Institute , Duke University , Durham, NC , USA ; Department of Pediatrics , Duke University Medical Center , Durham, NC , USA.

PMID: 26413278 PMCID: PMC4581382 DOI: 10.1093/ckj/sfv063

Abstract

BACKGROUND: Mutations in podocin (NPHS2) are the most common cause of childhood onset autosomal recessive steroid-resistant nephrotic syndrome (SRNS). The disease is characterized by early-onset proteinuria, resistance to immunosuppressive therapy and rapid progression to end-stage renal disease. Compound heterozygous changes involving the podocin variant R229Q combined with another pathogenic mutation have been associated with a mild phenotype with disease onset often in adulthood.

METHODS: We screened 19 families with early-onset SRNS for mutations in NPHS2 and WT1 and identified four disease-causing mutations (three in NPHS2 and one in WT1) prior to planned whole-exome sequencing.

RESULTS: We describe two families with three individuals presenting in childhood who are compound heterozygous for R229Q and one other pathogenic NPHS2 mutation, either L327F or A297V. One child presented at age 4 years (A297V plus R229Q) and the other two at age 13 (L327F plus R229Q), one with steadily deteriorating renal function.

CONCLUSIONS: These cases highlight the phenotypic variability associated with the NPHS2 R229Q variant plus pathogenic mutation. Individuals may present with early aggressive disease.

Keywords: FSGS; NPHS2; familial; hereditary; nephrotic syndrome; proteinuria

References

  1. Clin J Am Soc Nephrol. 2011 Feb;6(2):344-54 - PubMed
  2. Nat Genet. 1995 Apr;9(4):358-64 - PubMed
  3. Nat Genet. 2000 Apr;24(4):349-54 - PubMed
  4. Kidney Int. 2003 Jul;64(1):365 - PubMed
  5. Pediatr Nephrol. 2010 Sep;25(9):1621-32 - PubMed
  6. J Clin Invest. 2002 Dec;110(11):1659-66 - PubMed
  7. Nat Genet. 2014 Mar;46(3):299-304 - PubMed
  8. J Am Soc Nephrol. 2015 Jun;26(6):1279-89 - PubMed
  9. Nephrol Dial Transplant. 2014 Nov;29(11):2062-9 - PubMed
  10. Kidney Int. 2009 Apr;75(7):727-35 - PubMed
  11. Pediatr Nephrol. 2013 Oct;28(10):2061-4 - PubMed
  12. J Am Soc Nephrol. 2002 Feb;13(2):388-93 - PubMed
  13. Int Urol Nephrol. 2014 Jul;46(7):1383-93 - PubMed
  14. Kidney Int. 2004 Mar;65(3):1026-30 - PubMed
  15. Kidney Int. 2013 Jul;84(1):206-13 - PubMed
  16. Hum Mutat. 2014 Feb;35(2):178-86 - PubMed
  17. Am J Pathol. 2002 Jan;160(1):131-9 - PubMed
  18. Clin J Am Soc Nephrol. 2009 Jun;4(6):1065-72 - PubMed

Publication Types

Grant support